Nilotinib Efficacy According to Baseline BCR-ABL Mutations in Patients with Imatinib-Resistant Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
暂无分享,去创建一个
Martin C. Müller | J. Radich | G. Martinelli | G. Saglio | P. Erben | S. Soverini | A. Hochhaus | Dong-Wook Kim | T. Hughes | S. Branford | A. Haque | Y. Shou | T. Hughes | A. Hochhaus | M. Müller